Cantai Therapeutics

Cantai Therapeutics is advancing drugs for the treatment of autoimmune and inflammatory diseases by developing cytokines that target bispecific antibodies. The agent conceived this idea for Cantai's products and collaborated with 82VS to further develop the concept.